These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 15207785)

  • 1. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis.
    Török HP; Glas J; Tonenchi L; Mussack T; Folwaczny C
    Clin Immunol; 2004 Jul; 112(1):85-91. PubMed ID: 15207785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.
    Franchimont D; Vermeire S; El Housni H; Pierik M; Van Steen K; Gustot T; Quertinmont E; Abramowicz M; Van Gossum A; Devière J; Rutgeerts P
    Gut; 2004 Jul; 53(7):987-92. PubMed ID: 15194649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease.
    Tal G; Mandelberg A; Dalal I; Cesar K; Somekh E; Tal A; Oron A; Itskovich S; Ballin A; Houri S; Beigelman A; Lider O; Rechavi G; Amariglio N
    J Infect Dis; 2004 Jun; 189(11):2057-63. PubMed ID: 15143473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
    Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
    Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis.
    Wang F; Tahara T; Arisawa T; Shibata T; Nakamura M; Fujita H; Iwata M; Kamiya Y; Nagasaka M; Takahama K; Watanabe M; Hirata I; Nakano H
    J Gastroenterol Hepatol; 2007 Jun; 22(6):925-9. PubMed ID: 17565650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings.
    Michel O; LeVan TD; Stern D; Dentener M; Thorn J; Gnat D; Beijer ML; Cochaux P; Holt PG; Martinez FD; Rylander R
    J Allergy Clin Immunol; 2003 Nov; 112(5):923-9. PubMed ID: 14610481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
    Gazouli M; Mantzaris G; Kotsinas A; Zacharatos P; Papalambros E; Archimandritis A; Ikonomopoulos J; Gorgoulis VG
    World J Gastroenterol; 2005 Feb; 11(5):681-5. PubMed ID: 15655821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections.
    Agnese DM; Calvano JE; Hahm SJ; Coyle SM; Corbett SA; Calvano SE; Lowry SF
    J Infect Dis; 2002 Nov; 186(10):1522-5. PubMed ID: 12404174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease.
    Griga T; Wilkens C; Schmiegel W; Folwaczny C; Hagedorn M; Duerig N; Epplen J; Klein W
    Eur J Med Res; 2005 May; 10(5):183-6. PubMed ID: 15946916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively.
    Sashio H; Tamura K; Ito R; Yamamoto Y; Bamba H; Kosaka T; Fukui S; Sawada K; Fukuda Y; Tamura K; Satomi M; Shimoyama T; Furuyama J
    Immunogenetics; 2002 Mar; 53(12):1020-7. PubMed ID: 11904678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians.
    Juyal G; Amre D; Midha V; Sood A; Seidman E; Thelma BK
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1325-32. PubMed ID: 17892524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis.
    van der Paardt M; Crusius JB; de Koning MH; Morré SA; van de Stadt RJ; Dijkmans BA; Peña AS; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2005 Feb; 64(2):235-8. PubMed ID: 15647432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
    Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
    Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
    Pierik M; Vermeire S; Steen KV; Joossens S; Claessens G; Vlietinck R; Rutgeerts P
    Aliment Pharmacol Ther; 2004 Aug; 20(3):303-10. PubMed ID: 15274667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis.
    Meena NK; Verma R; Verma N; Ahuja V; Paul J
    J Clin Gastroenterol; 2013 Oct; 47(9):773-80. PubMed ID: 23470644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.